Verium investors, alongside the management team, have acquired a controlling stake in Zünd Präzisionsoptik and Optivac, ensuring continuity and capitalizing on growth opportunities in the precision optics sector.

Target Company Overview

Verium investors, in conjunction with the management team, are acquiring a controlling stake in Zünd Präzisionsoptik and Optivac, collectively referred to as the "Zünd Group." René Zünd, who has been instrumental to the company, will retain a significant ownership stake and continue his engagement in the business, ensuring continuity and a seamless transition. To enhance the company's governance, Verium will add Damian Stricker and George Merk to the board of directors, while Christian Velez, founder and CEO of Exalos, will also join the board bringing extensive industry experience.

Industry Overview in Switzerland

The Zünd Group operates in a highly specialized niche in the optics and precision engineering sector within Switzerland. This sector is characterized by technological innovation and stringent quality standards, which Swiss companies are renowned for internationally. The Swiss manufacturing industry benefits from a robust skill base and a highly educated workforce, which contributes to its competitive edge in precision products.

In recent years, there has been a notable growth trajectory in the field of minimally invasive surgical technologies and robotic systems, enhancing the demand for precision op

View Source

Similar Deals

KKA Partners BLACKROLL

2025

Management Buyout / Buy-In (MBO) Advanced Medical Equipment & Technology (NEC) Switzerland
ARCHIMED Stragen Pharma

2023

Management Buyout / Buy-In (MBO) Generic Pharmaceuticals Switzerland
Liberta Partners forteq Nidau AG

2023

Management Buyout / Buy-In (MBO) Medical Devices & Implants Switzerland
ARCHIMED MediStream

2023

Management Buyout / Buy-In (MBO) Medical Devices & Implants Switzerland
DeepTech & Climate Fonds NUCLIDIUM AG

2025

Series B Bio Therapeutic Drugs Switzerland
Galenica AG Diagnostics Group GmbH

2025

Buyout Medical & Diagnostic Laboratories Switzerland

Verium-Investoren

invested in

Zünd Präzisionsoptik und der Optivac

in

in a Management Buyout / Buy-In (MBO) deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert